Promising urine test could improve early detection and clinical management of bladder cancer: IARC Evidence Summary Brief No. 3

The International Agency for Research on Cancer (IARC) has released a new IARC Evidence Summary Brief, titled “Improving Early Detection and Clinical Management of Bladder Cancer”, in which researchers from IARC and partners argue for the validation of a simple and cost-effective urine test that could significantly improve early detection and management of bladder cancer, including among high-risk populations.

This IARC Evidence Summary Brief is the third in a series of scientific Evidence Summary Briefs published by IARC to call attention to the findings of evidence-based studies in key aspects of cancer prevention.

Read IARC Press Release 314 

Read IARC Evidence Summary Brief No. 3 

View the related videos

Read more about the IARC Evidence Summary Briefs series